<DOC>
	<DOCNO>NCT00090064</DOCNO>
	<brief_summary>This study conduct find methylenedioxymethamphetamine ( MDMA ) -assisted psychotherapy safe help people posttraumatic stress disorder ( PTSD ) arise victim crime .</brief_summary>
	<brief_title>A Test MDMA-Assisted Psychotherapy People With Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Posttraumatic stress disorder ( PTSD ) occur response traumatic event event . It likely occur follow event involve perceive personal threat , rape physical assault . PTSD clearly public health problem cause great deal suffer account significant portion health care cost . This study examine whether two session methylenedioxymethamphetamine ( MDMA ) -assisted psychotherapy safely administer participant PTSD , whether MDMA-assisted psychotherapy , compare placebo-assisted therapy , reduce PTSD symptom session two month second session . MDMA substance possess unique effect make well suit intensive psychotherapy . MDMA hypothesize represent new class drug , call entactogens , produce feeling closeness others , empathy , well , insightfulness . Currently , MDMA schedule ( illegal ) use outside research study like one . Anecdotal report therapy conduct MDMA make illegal suggest MDMA-assisted psychotherapy may benefit people PTSD . This study examine MDMA-assisted psychotherapy twenty people age 18 70 PTSD either relate crime victimization combat , combat-related PTSD last longer five year , get good psychotherapy treatment SSRI ( selective serotonin uptake inhibitor , Paxil ) . This study last three four month . Participants attend fourteen ( 14 ) ordinary ( non-drug ) psychotherapy session investigator well two eight hour long experimental ( MDMA placebo ) sessions one MDMA session . People take part study take psychiatric medication study period . People either get 125 mg MDMA placebo `` chance , '' coin-toss , twelve twenty ( 60 % ) get MDMA experimental session , eight twenty ( 40 % ) get placebo . Two two half hour later , investigator agree alright , take second supplemental , dose MDMA placebo . The supplemental dose half size first dose . The investigator conduct non-drug therapy session conduct experimental session . All participant require stay night clinic experimental session . Participants meet investigator non-drug assisted therapy session day experimental session . A third MDMA session placebo-controlled stage study people receive MDMA first two session . PTSD symptom measure start study , four day experimental session , finally two month second experimental session . People test memory problem solve first enter study two month second experimental session . PTSD symptom measure see whether change symptom study , test think , memory problem-solving meant spot change could due MDMA MDMA-assisted therapy . Participants recieved MDMA complete final evaluation , upon discussion investigator , undergo third MDMA session . The third session happen approximately two month second experimental session This session `` open label , '' mean investigator know receive MDMA . It follow one psychotherapy session day session two additional psychotherapy session follow week . PTSD symptom measure two month third MDMA session . Participants receive placebo complete final evaluation two month second experimental procedure give opportunity take part open-label continuation study receive initial dose 125 mg MDMA supplemental dose 62.5 mg MDMA three experimental session schedule three five week apart . Participants open-label continuation act control . The open-label continuation last three month involve nine visit investigator , include two experimental session .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<criteria>Be diagnose chronic PTSD , duration 5 year longer result traumatic experience military service victim crime ; Have CAPS score show moderate severe PTSD symptom ; 1 . Have least one unsuccessful attempt treatment PTSD either talk therapy drug , discontinue treatment inability tolerate psychotherapy drug therapy . 2 . Are least 18 year old ; Must generally healthy ; Must sign medical release investigator communicate directly therapist doctor ; Are willing refrain take psychiatric medication study period ; Willing follow restriction guideline concern consumption food , beverage , nicotine night prior experimental session ; Willing remain overnight study site ; Agree transportation drive home stay integrative session day MDMA session ; willing contacted via telephone necessary telephone contact ; Must negative pregnancy test able bear child , agree use effective form birth control ; must provide contact event participant become suicidal ; Are proficient speak read English ; agree clinic visit session record audio video Agree participate interventional clinical trial duration study . Are pregnant nursing , woman child , practice effective mean birth control ; Weigh le 50 kg ; Are abuse illegal drug ; Are unable give adequate inform consent ; Upon review past current drugs/medication must take medication exclusionary . Upon review medical psychiatric history must current past diagnosis would consider risk participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>MDMA</keyword>
	<keyword>Methylenedioxymethamphetamine</keyword>
	<keyword>PTSD</keyword>
	<keyword>psychotherapy</keyword>
</DOC>